课题基金 / 基金详情

Quantitative Immunological Assays to Assess HIV Antibodies and Vaccines

Quantitative Immunological Assays to Assess HIV Antibodies and Vaccines
评估 HIV 抗体和疫苗的定量免疫分析
批准号:
10928625
负责人:
Nicole Doria-Rose
金额:
$89.24万
依托单位国家:
美国
项目类别:
财政年份:
--
资助国家:
美国
项目状态:
未结题
起止时间:

项目摘要

项目成果

Nicole Doria-Rose的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
We are a Core lab providing HIV antibody assay services to labs within the Vaccine Research Center, other intramural labs, and for collaborators around the world. Most of our work uses a standardized HIV-1 neutralization assay. We perform this assay on serum samples from vaccinated animals and HIV-infected individuals, on antibodies isolated from such subjects, and on variant antibodies engineered for improved breadth, potency, and manufacturability. We also develop and maintain the reagents needed for these assays, including natural and mutant virus genes, stocks of viruses, and stocks of reference antibodies. We recently have increased the throughput of our assay by integrating robotic liquid handling into our protocols. In addition, we provide analysis and graphics to allow interpretation of our data, as well as related data from the VRC VIP lab; these are being used for selection of candidate clinical products at the VRC and by collaborators. We also provide data to collaborators at a pharma company to inform their decisions on developing products for clinical trials.
期刊论文(1)
专著(0)
科研奖励(0)
会议论文
Quantitative Immunological Assays to Assess SARS-CoV-2 Antibodies and Vaccines
Quantitative Immunological Assays to Assess SARS-CoV-2 Antibodies and Vaccines
HIV Neutralizing Antibodies: Isolation, characterization, and interaction with viral variants
海外基金